EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 50 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $634,000 | -7.3% | 64,380 | +31.4% | 0.04% | -38.7% |
| Q4 2017 | $684,000 | -32.8% | 49,000 | -47.0% | 0.06% | -7.5% |
| Q3 2017 | $1,018,000 | -42.2% | 92,500 | -58.5% | 0.07% | -41.7% |
| Q2 2017 | $1,762,000 | -35.6% | 223,100 | -6.6% | 0.12% | -22.3% |
| Q1 2017 | $2,735,000 | -2.4% | 238,907 | -0.7% | 0.15% | -9.2% |
| Q4 2016 | $2,802,000 | -9.3% | 240,541 | +4.2% | 0.16% | +40.5% |
| Q3 2016 | $3,090,000 | -11.0% | 230,803 | +31.7% | 0.12% | -35.9% |
| Q2 2016 | $3,473,000 | -20.2% | 175,249 | -32.5% | 0.18% | -17.0% |
| Q1 2016 | $4,354,000 | – | 259,643 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 694,232 | $8,532,000 | 5.82% |
| P.A.W. CAPITAL CORP | 400,000 | $4,916,000 | 4.34% |
| Telemetry Investments, L.L.C. | 128,848 | $1,584,000 | 2.68% |
| Trellus Management Company, LLC | 206,404 | $2,537,000 | 2.09% |
| KNOTT DAVID M | 295,035 | $3,626,000 | 1.64% |
| 683 Capital Management, LLC | 2,683,600 | $32,982,000 | 1.56% |
| INTERWEST VENTURE MANAGEMENT CO | 764,918 | $9,401,000 | 1.17% |
| TOWERVIEW LLC | 130,000 | $1,598,000 | 1.14% |
| Vivo Capital, LLC | 1,791,257 | $22,015,000 | 0.98% |
| Altium Capital Management LP | 197,500 | $2,427,000 | 0.91% |